Novartis AG vs Star Bulk Carriers Corp — how do they compare? Novartis AG trades at $153.88 (market cap $290.25B), while Star Bulk Carriers Corp trades at $26.63 (market cap $2.91B). The key difference: Novartis AG is far larger — about 99.7× Star Bulk Carriers Corp's market cap, and Star Bulk Carriers Corp pays the higher dividend (3.95%). Which is the better fit depends on your goals.
| NVS | SBLK | |
|---|---|---|
Market Cap | $290.25B | $2.91B |
Sector | Health | Industrials |
52-Week High | $168.62 | $28.21 |
52-Week Low | $113.50 | $16.79 |
Enterprise Value | $330.27B | $3.61B |
Dividend Yield | 3.17% | 3.95% |
Trailing returns across standard periods
Latest headlines on both assets
Novartis develops and manufactures healthcare products through two segments: Innovative Medicines and Sandoz. It generates the vast majority of its revenue from Innovative Medicines segment consisting global business franchises in oncology, ophthalmology, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.
Read more on NVS →Star Bulk Carriers Corp. is a global shipping company specializing in the seaborne transportation of dry bulk commodities. The company owns and operates a large fleet of bulk carriers, primarily transporting major commodities such as iron ore, coal, and grain. SBLK focuses on the Capesize, Post Panamax, and Kamsarmax vessel segments, providing critical logistical services to commodity producers and consumers worldwide.
Read more on SBLK →